My Amyloid Doc Put Out Another Article

Durable remissions and prolonged survival for patients with immunoglobulin light chain amyloidosis (AL), a plasma cell dyscrasia, have been achieved with high-dose chemotherapy and autologous stem cell transplantation, investigators here reported.

The investigators said that "the fact that the outcome is so strongly dependent upon achieving a hematologic complete response indicates that treatment response plays an important role in long-term survival."

You want numbers and statistics? This article, written by my amyloid doctor over at Boston Medical, has a ton of them.

Aggressive Treatment Boosts Survival in AL Amyloidosis - Breaking Medical News + CME Teaching Brief® - MedPage Today

Powered by ScribeFire.